Clinical Features of Patients With COVID‐19 With Nonalcoholic Fatty Liver Disease

Rui Huang, Li Zhu, Jian Wang, Leyang Xue, Longgen Liu, Xuebing Yan, Songping Huang, Yang Li, Xiaomin Yan, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Juan Cheng, Yinling Wang, Haiyan Zhao, Shuqin Hong, Kang Chen, Xiang‐an Zhao, Lei Zou, Dawen Sang, Huaping Shao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Jie Wei, Chuanwu Zhu, Chao Wu – 6 August 2020 – Previous studies reported that coronavirus disease 2019 (COVID‐19) was likely to result in liver injury. However, few studies investigated liver injury in patients with COVID‐19 with chronic liver diseases.

Clinical Features of Patients With COVID‐19 With Nonalcoholic Fatty Liver Disease

Rui Huang, Li Zhu, Jian Wang, Leyang Xue, Longgen Liu, Xuebing Yan, Songping Huang, Yang Li, Xiaomin Yan, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Juan Cheng, Yinling Wang, Haiyan Zhao, Shuqin Hong, Kang Chen, Xiang‐an Zhao, Lei Zou, Dawen Sang, Huaping Shao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Jie Wei, Chuanwu Zhu, Chao Wu – 6 August 2020 – Previous studies reported that coronavirus disease 2019 (COVID‐19) was likely to result in liver injury. However, few studies investigated liver injury in patients with COVID‐19 with chronic liver diseases.

Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease

Benjamin L. Shneider, Nathan P. Goodrich, Wen Ye, Cindy Sawyers, Jean P. Molleston, Robert M. Merion, Daniel H. Leung, Saul J. Karpen, Binita M. Kamath, Laurel Cavallo, Kasper Wang, Jeffrey H. Teckman, James E. Squires, Shikha S. Sundaram, Philip Rosenthal, Rene Romero, Karen F. Murray, Kathleen M. Loomes, M. Kyle Jensen, Jorge A. Bezerra, Lee M. Bass, Ronald J. Sokol, John C. Magee, For the Childhood Liver Disease Research Network (ChiLDReN) – 5 August 2020 – Elastographic measurement of liver stiffness is of growing importance in the assessment of liver disease.

Differential Impact of Extended Criteria Donors After Brain Death or Circulatory Death in Adult Liver Transplantation

Keval Pandya, Vinay Sastry, Mara T. Panlilio, Terry C. F. Yip, Shirin Salimi, Claire West, Susan Virtue, Mark Wells, Michael Crawford, Carlo Pulitano, Simone I. Strasser, Geoffrey W. McCaughan, Avik Majumdar, Ken Liu – 4 August 2020 – Using grafts from extended criteria donors (ECDs) and donation after circulatory death (DCD) donors is a strategy to address organ shortage in liver transplantation (LT). We studied the characteristics and outcomes of ECD and DCD grafts. We retrospectively studied consecutive adults who underwent deceased donor LT between 2006 and 2019.

Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors

Paul Winograd, Shuang Hou, Colin M. Court, Yi‐Te Lee, Pin‐Jung Chen, Yazhen Zhu, Saeed Sadeghi, Richard S. Finn, Pai‐Chi Teng, Jasmin J. Wang, Zhicheng Zhang, Hongtao Liu, Ronald W. Busuttil, James S Tomlinson, Hsian‐Rong Tseng, Vatche G. Agopian – 4 August 2020 – Hepatocellular carcinoma (HCC) is a leading cause of mortality. Checkpoint inhibitors of programmed cell death protein‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have shown great efficacy, but lack biomarkers that predict response.

Subscribe to